Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies

✍ Scribed by Prof. Cl. Jacquillat; M. Weil; M. F. Gemon-Auclerc; V. Izrael; A. Bussel; M. Boiron; Jean Bernard

• Publisher: John Wiley and Sons
• Year: 1976
• Tongue: English
• Weight: 441 KB
• Volume: 37
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/1097-0142(197602)37:2<653::aid-cncr2820370207>3.0.co;2-q

✦ Synopsis

Rubidazone was